Ed Gudaitis Archives - The Canadian Business Quarterly

Ed Gudaitis

Acerus Pharmaceuticals (TSX:ASP | OTCQB:ASPCF): Building a sustainable, value-driven company

December 4, 2020 / The Canadian Business Quarterly

A TSX-listed commercial-stage pharmaceutical company, Acerus Pharmaceuticals has a vision to become a leading specialty pharmaceutical company focused on urology and Men’s Health with its nasal testosterone treatment, Natesto. Founded

Sodexo Canada: The global leader who believes the difference a day makes

Barclay Restorations DKI: The longest running insurance restoration company in Greater Vancouver

CDW Canada: Helping small businesses use IT security to prepare, defend, and respond

Stamped Engineering Corporation: High quality, fit for purpose engineering services

Alpine Building Maintenance: Customized cleaning solutions

Case Design/Remodeling Halifax: Flawless design and execution

Weston Wood Solutions: One of Canada’s fastest growing companies

CDW Canada: Helping organizations navigate a complex IT market

Reclaiming Canada’s key service export: Tourism

Concerning signs for Canada’s construction sector in 2023

Strengthening your organization through sustainability & ESG

55% of provincial healthcare budgets will be for seniors by 2030

Spymasters, conspiracies, the PRC, & Dong Jingwei

Digital transformations on the wrong end of the stick

It’s impossible to tackle climate change without nuclear

Inflation: Demand creates its own supply

Ed Gudaitis

Acerus Pharmaceuticals (TSX:ASP | OTCQB:ASPCF): Building a sustainable, value-driven company

Subscribe

Subscribe

© 2023 The Canadian Business Quarterly. All rights reserved. A division of Romulus Rising Pty Ltd, an Australian media company (www.RomulusRising.com).